A Phase II Study Of Trabectedin (ET-743, Yondelis RM) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2018
At a glance
- Drugs Trabectedin (Primary)
- Indications Ewing's sarcoma; Rhabdomyosarcoma; Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- 08 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Apr 2010 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 May 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.